A Phase II Multicentre Study with Elacytarabine as Second Salvage Therapy in Patients with AML.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • O'Brien, S; Rizzieri, DA; Vey, N; Ravandi, F; Krug, UO; Sekeres, MA; Dennis, M; Venditti, A; Jacobsen, TF; Staudacher, K; Nilsson, BI; Giles, FJ

Published Date

  • November 20, 2009

Published In

Volume / Issue

  • 114 / 22

Start / End Page

  • 431 - 431

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 51st Annual Meeting of the American-Society-of-Hematology

Conference Location

  • New Orleans, LA

Conference Start Date

  • December 5, 2009

Conference End Date

  • December 8, 2009